|
|||||||||
|
|
|||||||||
| Case Report | |||||||||
|
|
|||||||||
| Volume 2, Number 5, October 2011, pages 197-200 | |||||||||
|
|
|||||||||
|
Paraneoplastic Acanthosis Nigricans, Leser-Trélat and Tripe Palms Associated With Gastro-Esophageal Junction
Adenocarcinoma: A Case Report
Pieter van Hagena,
c,
Bas P.L. Wijnhovena,
Lizenka A. Torcqueb,
Huug W. Tilanusa,
J. Jan B. van Lanschota,
Errol P. Prensb
aDepartment
of Surgery, Erasmus University Medical Center Rotterdam, ‘s
Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands
Manuscript
accepted for publication
May
11,
2010
Abstract
Acanthosis nigricans is a skin condition that is characterized by
velvety, hyperpigmented and occasionally pruritic plaques, mostly
seen in the flexural areas. It can occur as a paraneoplastic
phenomenon, most frequently in association with an adenocarcinoma of
gastrointestinal origin. The sign of Leser-Trélat is defined as an
eruption of numerous seborrheic keratoses, and can be associated
with acanthosis nigricans. Also, acanthosis nigricans can be
associated with tripe palms, a velvety, warty thickening of the
palms’ surface with exaggerated dermatoglyphics, and with
papillomatosis of the oral mucosa. A 62-year old woman presented with a rapid onset of
hyperpigmented plaques, multiple (seborrheic) warts, tripe palms and
papillomatous hyperplasia of her oral mucosa. A skin biopsy
confirmed acanthosis nigricans. Because of her age and the quite
sudden development of the skin lesions, the paraneoplastic variant
of this condition was suspected and the patient was referred to a
medical oncologist. As part of extensive diagnostic screening, an
upper gastro-intestinal endoscopy was performed revealing an
esophageal tumor at 30 to 35 cm from the incisors. She underwent an
esophagectomy after neoadjuvant chemoradiotherapy. The tumor was
staged as ypT2N1M0 adenocarcinoma, which had been radically resected
(R0). The tumor showed extensive histomorphological regression.
During the neoadjuvant therapy the skin lesions and the mucosal
swelling with which the patient initially presented regressed, and
disappeared almost completely six months after surgery. The
presented case shows the combination of acanthosis nigricans, the
sign of Leser-Trélat, tripe palms and extensive oral papillomatosis,
which led to the detection of an adenocarcinoma of the
gastro-esophageal junction, a tumor that has been reported in
association with malignant acanthosis nigricans. Keywords: Acanthosis nigricans; Paraneoplastic syndromes; Esophagogastric junction; Esophageal neoplasms
Introduction Acanthosis nigricans (AN) is a skin disorder that is characterized by velvety, papillomatous, hyperpigmented and occasionally pruritic plaques, mostly seen in the flexural areas. The disorder in itself is benign and associated with insulin resistance, obesity, erythema nodosum and medication (sex hormones, nicotinic acid). AN can also present as a paraneoplastic syndrome and is associated with several malignancies, mostly adenocarcinomas of gastrointestinal origin [1]. AN is most often associated with (distal) gastric cancer, followed by cancers originating from pancreas, ovaries, kidneys, bladder, bronchi, thyroid gland, bile duct and breast. AN is rarely associated with non-epithelial malignancies [2]. In combination with the skin lesions that are typical for AN, the sudden appearance of seborrheic keratosis (the sign of Leser-Trélat) can be seen, resulting in an eruption of multiple seborrheic warts on the trunk. Another skin condition associated with AN is tripe palms, a thickened, velvety, warty surface of the hands with exaggerated dermatoglyphics [3].
Furthermore, AN is the only paraneoplastic syndrome that can involve
the oral mucosa, sometimes leading to papillomatosis of the
oropharyngeal epithelium [4].
Moreover, multiple wart-like lesions, mostly on the extremities,
called florid cutaneous papillomatosis can occur in association with
AN. As the paraneoplastic variant of AN frequently has an onset
before patients have any other complaints, it is not uncommon that
an underlying malignancy is discovered long after AN has been
diagnosed [5].
This case report presents the combination of all the paraneoplastic
syndromes mentioned above in a patient with a gastro-esophageal
junction carcinoma.
Case
Report
Already during the neoadjuvant chemoradiotherapy, the AN showed
clear signs of regression. Apart from a superficial wound infection,
the postoperative recovery was uneventful and the patient was
discharged on postoperative day 14. Histopathologic examination of
the resection specimen showed an ypT2N1M0, poorly differentiated
adenocarcinoma (G3) that had been radically removed (R0). After six
months of follow-up, the acanthosis nigricans (Fig.
1B),
as well as the Leser-Trélat sign (Fig.
2B),
the tripe palms, the oral (Fig.
3B)
and cutaneous papillomatosis were in complete regression, without
any specific dermatological therapy. Discussion Acanthosis nigricans is a disorder characterized by hyperpigmented, papillomatous, velvety plaques, located in the skin folds. The disorder can be roughly divided into a benign and a paraneoplastic type, which can be distinguished from each other neither by dermatologic investigation nor by histopathologic examination [6]. The benign form is often familial, associated with endocrine pathology (for example insulin resistance or hyperandrogenism) or hormonal substitution therapy but can also be congenital. ‘Malignant’ AN is a paraneoplastic syndrome and not a malignancy in itself. It is not unusual for AN to precede the diagnosis of the primary tumor [5]. If the diagnosis of paraneoplastic AN is not suspected immediately, and a patient is treated as having benign AN, a serious delay in the diagnosis and treatment of the underlying malignancy can occur [1]. Patients presenting with a rapid onset of extensive AN or coexisting unintentional weight loss should be suspected of having paraneoplastic AN. Also, patients who present with AN in combination with the sign of Leser-Trélat, tripe palms or mucosal involvement have a higher risk of having paraneoplastic AN [7]. When paraneoplastic AN is suspected, a wide variety of primary malignancies should be considered. Most common are (distal) gastric carcinomas, but also pancreatic, ovarian, renal and other abdominal carcinomas are common [8]. Patients who are suspected of having paraneoplastic AN should therefore undergo extensive investigations, covering all possible tumors associated with AN, preferably in order of suspicion. This means that patients should be interviewed extensively about all possible complaints, and that a thorough physical examination should be performed. When after these first investigations a certain malignancy is suspected, this should of course be the focus of further investigation. If, however, a malignancy is not found on the suspected location, investigations should proceed until it is confirmed that on all possible locations where a malignancy could be present, there is none. In the present case, AN was associated with a GE-junction adenocarcinoma. The present case is especially interesting because AN was associated with the sign of Leser-Trélat and tripe palms and extensive oral papillomatosis. The sign of Leser-Trélat is defined as the appearance of multiple seborrheic verrucous keratoses, and is regularly seen in combination with paraneoplastic AN. It can however also occur without the presence of AN, can be associated with malignant and benign conditions, but has never been reported in combination with benign AN [9, 10]. To our knowledge, the combination of AN, Leser-Trélat, tripe palms plus extensive papillomatosis of the oral mucosa in association with a carcinoma of the gastro-esophageal junction has never been described before. The pathologic mechanism that causes paraneoplastic AN is unknown. It has been hypothesized that tumor-produced growth factors such as epidermal growth factor, transforming growth factor-α, insulin-like growth factor-1, fibroblast growth factor and melanocyte stimulating hormone-α play a central role [11]. It is believed that when these growth factors are produced by the primary tumor and circulate in large quantities, they can cause epidermal cells to proliferate [11]. Other possibilities, such as a systemic immunologic response to the primary tumor as a cause of the disorder, cannot be discarded. The optimal treatment of paraneoplastic AN differs between individual cases. Some cases are resistant to any form of therapy, even if the patient is successfully treated for the associated malignancy [12]. Fortunately, in some cases, no separate treatment is needed for AN, as it fully regresses when the associated tumor is effectively treated [7, 13]. This was also the case in the presented patient. However, symptomatic treatment (e.g. anti-pruritic therapy) of the skin lesions can be needed while the patient waits for treatment of the underlying tumor [1]. It has been described that benign AN recurs after the treatment of an underlying endocrine disorder is stopped [14-16]. To our knowledge, no cases of recurrent AN due to a recurrence of the primary tumor have been described. If AN is a general prognosticator for long term survival is unknown. Only in ovarian cancer, it has been described as an indicator of poor prognosis [17]. The esophageal polyps that were found in the present case, could be considered as another expression of AN, which has been described previously [18]. Also, the hair loss from which the patient suffered has been described in literature as an accompanying symptom of AN [4].
The
present case shows the rare combination of acanthosis nigricans,
sudden appearance of seborrheic keratosis with verrucae (the sign of
Leser-Trélat), tripe palms and extensive oral and cutaneous
papillomatosis, which led to the diagnosis of (asymptomatic) cancer
at the gastro-esophageal junction, a tumor that is rarely associated
with paraneoplastic AN. A patient over 40 years old presenting with
sudden onset of AN should always be suspected of having
paraneoplastic AN, especially when AN is accompanied with the sign
of Leser-Trélat, tripe palms and/or oral papillomatosis. When a
patient is suspected of having paraneoplastic AN, extensive
investigation should take place to find a possible underlying
malignancy. Conflicts of Interest
The
authors declare no conflict of interest. Written informed consent
was obtained from the patient for publication of this case report
and all accompanying images. Acknowledgement PvH, BW, LT, HT, JvL and EP wrote and/or revised the manuscript. PvH, LT and EP provided the clinical data and the photographs. There is no grant support. |
|||||||||
|
|
|||||||||
| References | |||||||||
| 1. |
Krawczyk M, Mykala-Ciesla
J, Kolodziej-Jaskula A. Acanthosis nigricans as a paraneoplastic
syndrome. Case reports and review of literature.
Pol Arch Med Wewn. 2009;119(3):180-183. [Medline] |
| 2. |
Curth HO,
Hilberg AW, Machacek GF. The site and histology of the cancer associated
with malignant acanthosis nigricans. Cancer. 1962;15:364-382. [Medline] |
| 3. |
Cohen PR, Grossman ME,
Silvers DN, Kurzrock R. Tripe palms and cancer.
Clin Dermatol. 1993;11(1):165-173. [Medline] [CrossRef] |
| 4. |
Steen AE, Steen KH, Bieber
T. Multiple paraneoplasia in the absence of a detectable tumour.
Acta Derm Venereol. 2001;81(2):150-151. [Medline] [CrossRef] |
| 5. | Odom RB, James WD, Berger TG. Andrews' diseases of the skin : clinical dermatology. 9th ed. Philadelphia: W.B. Saunders, 2000. |
| 6. |
Flier JS. Metabolic
importance of acanthosis nigricans.
Arch Dermatol. 1985;121(2):193-194. [Medline] [CrossRef] |
| 7. |
Higgins SP, Freemark M,
Prose NS. Acanthosis nigricans: a practical approach to evaluation and
management. Dermatol Online J.
2008;14(9):2. [Medline] |
| 8. |
Rigel DS, Jacobs MI.
Malignant acanthosis nigricans: a review.
J Dermatol Surg Oncol. 1980;6(11):923-927. [Medline] |
| 9. |
Heaphy MR, Jr., Millns JL,
Schroeter AL. The sign of Leser-Trelat in a case of adenocarcinoma of
the lung. J Am Acad Dermatol.
2000;43(2 Pt
2):386-390. [Medline] [CrossRef] |
| 10. |
Yeh JS, Munn SE, Plunkett
TA, Harper PG, Hopster DJ, du Vivier AW. Coexistence of acanthosis
nigricans and the sign of Leser-Trelat in a patient with gastric
adenocarcinoma: a case report and literature review.
J Am Acad Dermatol. 2000;42(2
Pt 2):357-362. [Medline] [CrossRef] |
| 11. |
Koyama S, Ikeda K, Sato M,
Shibahara K, Yuhara K, Fukutomi H, Fukunaga K, et al. Transforming
growth factor-alpha (TGF alpha)-producing gastric carcinoma with
acanthosis nigricans: an endocrine effect of TGF alpha in the
pathogenesis of cutaneous paraneoplastic syndrome and epithelial
hyperplasia of the esophagus.
J Gastroenterol. 1997;32(1):71-77. [Medline] [CrossRef] |
| 12. |
Lenzner U, Ramsauer J,
Petzoldt W, Meigel W. Acanthosis nigricans maligna. Case report and
review of the literature.
Hautarzt. 1998;49(1):41-47. [Medline] |
| 13. |
Anderson SH, Hudson-Peacock
M, Muller AF. Malignant acanthosis nigricans: potential role of
chemotherapy. Br J Dermatol.
1999;141(4):714-716. [Medline] [CrossRef] |
| 14. |
Katz RA. Treatment of
acanthosis nigricans with oral isotretinoin.
Arch Dermatol. 1980;116(1):110-111. [Medline] [CrossRef] |
| 15. |
Ozdemir M, Toy H,
Mevlitoglu I, Demirkesen C. Generalized idiopathic acanthosis nigricans
treated with acitretin. J
Dermatolog Treat. 2006;17(1):54-56. [Medline] [CrossRef] |
| 16. |
Walling HW, Messingham M,
Myers LM, Mason CL, Strauss JS. Improvement of acanthosis nigricans on
isotretinoin and metformin. J
Drugs Dermatol. 2003;2(6):677-681. [Medline] |
| 17. |
Scheinfeld N. A review of
the cutaneous paraneoplastic associations and metastatic presentations
of ovarian carcinoma. Clin Exp
Dermatol. 2008;33(1):10-15. [Medline] |
| 18. |
Kozlowski LM, Nigra TP.
Esophageal acanthosis nigricans in association with adenocarcinoma from
an unknown primary site. J Am
Acad Dermatol. 1992;26(2 Pt 2):348-351. [Medline] [CrossRef] |
Digital Object Identifier (DOI):10.4021/jmc217w
About
DOI and
CrossRef
Journal of Medical Cases is a member of CrossRef.



